Bifogade filer
SenzaGen to present strong GARD®skin data at the world’s largest toxicology conference together with leading industry partners
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
SenzaGen, a developer and provider of advanced non-animal test methods based on genomics and machine learning, continues to strengthen its position as a thought leader in non-animal toxicology. From March 22–25, 2026, the company will present new scientific data at the SOT 65th Annual Meeting & ToxExpo, the world’s largest toxicology conference, together with several leading industry partners.
SOT is a central scientific forum where SenzaGen will highlight how the GARD® platform is being used by industry and how global demand for advanced non-animal test methods continues to grow. During the conference, the company will present the platform’s broad applicability and its unique strengths for assessing complex and challenging substances, as well as for quantitative risk assessment.
As part of the program, SenzaGen will present posters and host its own session featuring external speakers who will share their results and experiences with GARD®. These activities are organized in collaboration with several global companies including Johnson & Johnson MedTech, ExxonMobil (chemicals), Coty (fragrance and cosmetics), and Haleon (OTC pharmaceuticals), alongside researchers from SenzaGen.
“Through our program at this year’s SOT, we continue to reinforce our role as a thought leader while strengthening the position of the GARD® platform within the toxicology community. Having global companies such as ExxonMobil and Johnson & Johnson MedTech present their results on GARD® together with us reflects both the confidence in the technology and the clear shift toward non‑animal testing,” says Peter Nählstedt, President & CEO of SenzaGen.
During the conference, SenzaGen and its scientific partners will present new data within:
- Skin and respiratory sensitization
- Testing of challenging chemicals and formulations
- Evaluation of medical device materials
- Quantitative risk assessment (safe dose levels)
The SOT Annual Meeting & ToxExpo is organized by the Society of Toxicology and attracts approximately 5,000 scientists and experts from around the world each year.
Learn more about SenzaGen’s scientific program here:
https://senzagen.com/event/2026sot/